Prebiotic functional foods market is now worth £59 million to the EU economy, with 60% of all functional foods being directed towards gut interventions. As digestive difficulties are extremely common, there is a need for efficacious intervention that reduces the risk of gastroenteritis, inflammatory conditions and disorders that may have a systemic effect. While working at the University of Reading and during my appointment at Roehampton I have been focused on the efficacy of a second-generation prebiotic Bimuno supplied by Clasado Ltd (UK). Launched as a health food supplement in Boots, Bimuno can alter people’s gut flora and thereby positively affect gut bacteria in health and disease as confirmed by my publications’ record. To this end, I have recently been testing this prebiotic in Autistic Spectrum Disorders. Following an intervention with this prebiotic, my research has shown beneficial improvements in gut microbial profiles together with better sleeping patterns and social behavior in autism. This has been the first study where the effect of prebiotics has been evaluated in autism, showing potential beneficial effects. (Grimaldi et al., 2018)